The European Medicines Agency (EMA) published new guidance on April 16, 2026, aimed at streamlining the application pathways for paediatric medicines, providing clearer procedures for pharmaceutical companies seeking paediatric indications. The guidance impacts drug developers, regulatory authorities in EU member states, healthcare professionals, and paediatric patients.
The document, issued by the EMA's Paediatric Committee (PDCO), builds on the committee's recent work, including meeting minutes released on April 13, 2026, which detailed discussions on paediatric investigation plans (PIPs) and waivers. The new guidance seeks to reduce administrative burden and accelerate access to paediatric medicines by clarifying the requirements for PIP submissions and waivers.
Guidance Aims to Simplify PIP Procedures The guidance outlines streamlined processes for requesting PIPs and waivers, including updated templates and submission timelines. It emphasizes early dialogue between sponsors and the PDCO to avoid delays. This follows the EMA's April 9, 2026 proposal of a template for industry to share documents supporting regulatory reliance, which also aims to expedite marketing authorisations.
Impact on Stakeholders Pharmaceutical companies will benefit from clearer procedures, potentially reducing costs and time-to-market for paediatric medicines. However, they may face initial adaptation costs to align with new requirements. National health systems could see faster availability of paediatric treatments, improving patient outcomes. Healthcare professionals will gain earlier access to evidence-based paediatric therapies, while paediatric patients stand to benefit from more timely access to innovative medicines.
Expected Institutional Follow-Up The EMA plans to monitor the implementation of the guidance and may issue further updates based on stakeholder feedback. The PDCO will continue to assess PIPs and waivers under the revised framework, with the aim of harmonising paediatric medicine development across the EU.
← Atlas › News › Health & Lifestyle